The Remarkable Journey of Fondaparinux – Abdul Mannan
Dr. Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
“The Remarkable Journey of Fondaparinux:
The story begins with Jay McLean’s accidental discovery of heparin at Johns Hopkins in 1916. Decades later, Harvard and Uppsala scientists revealed heparin’s mechanism – supercharging antithrombin by 1000-fold.
The Breakthrough (1980s):
Researchers discovered a pentasaccharide sequence within heparin was responsible for anticoagulation – The exact key that unlocks antithrombin’s potential.The Innovation (1987):
Maurice Petitou’s team at Institut Choay achieved the impossible – synthesizing the first artificial pentasaccharide (SR90107A/Org31540): The fondaparinux.Clinical Success (2002):
Trials involving 7,000+ patients, fondaparinux (Arixtra) showed 55% RR reduction in VTE. Sanofi brought this revolutionary anticoagulant to market.Why It Matters:
– Selective Xa inhibition
– No HIT risk
– Fixed dosing , no monitoring
– Synthetic precision over natural variabilityThis journey shows how molecular insight transforms patient care. Fondaparinux remains key in VTE prevention and led to modern anticoagulants.
What breakthrough in hemostasis research inspires you most?”
Don’t miss the latest updates with Hemostasis Today.
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:33Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer OutcomesÂ
-
Oct 19, 2026, 05:44Mavis Agnes Kisakye: Raising Awareness about Haemophilia and Other Blood Disorders at Luweero General Hospital